Back to Search
CHRISTOPHER COUGHLIN, PHARM.D., BCOP
PHARM.D., BCOP
Oncology Pharmacist
NPI: 1548481815Individual
Specialties, Licenses & Credentials
Oncology PharmacistPrimary
Pharmacist — Oncology
Code: 1835X0200X
39299(TX)12251(AZ)
Research & Publications (20)
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts.
PMID 19509264·Mol Cancer Ther·2009
7-preclinical
Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children.
PMID 18951580·J Urol·2008
8-other
Apolipoprotein E epsilon4 allele and outcomes of traumatic spinal cord injury.
PMID 18581664·J Spinal Cord Med·2008
8-other
Development and implementation of a comprehensive strategic plan for medical education at an academic medical center.
PMID 18520458·Acad Med·2008
8-other
RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
PMID 18337841·Gene Ther·2008
7-preclinical
Effect of marked weight loss on adiponectin gene expression and plasma concentrations.
PMID 17372314·Obesity (Silver Spring)·2007
3-trial
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma.
PMID 17179106·J Clin Oncol·2006
8-other
Interferon beta adenoviral gene therapy in a patient with ovarian cancer.
PMID 17080181·Nat Clin Pract Oncol·2006
5-case
RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy.
PMID 14630810·Blood·2004
7-preclinical
Costs of broad-spectrum antibiotic use for acute sinusitis, chronic bronchitis, and pneumonia in a managed care population.
PMID 12841074·Manag Care Interface·2003
8-other
Care centered organizations, Part 2. The changing role of the nurse executives.
PMID 11263059·J Nurs Adm·2001
8-other
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.
PMID 11240234·Int J Radiat Oncol Biol Phys·2001
3-trial
Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507.
PMID 11181676·J Clin Oncol·2001
3-trial
Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
PMID 11121633·Int J Radiat Oncol Biol Phys·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD., UNIT 90
HOUSTON, TX 77030 - Phone
- (713) 792-2870
Quick Facts
- NPI
- 1548481815
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile